AGIOS PHARMACEUTICALS, INC. Stock-Based Compensation
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Stock-Based Compensation of $31.48 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-30
- AGIOS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $15.94M, a 8.50% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $15.54M, a 36.82% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $14.12M, a 29.54% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $12.38M, a 11.05% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $52.55M, a 22.65% increase from fiscal 2024.
- AGIOS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $42.85M, a 4.29% decline from fiscal 2023.
- AGIOS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $44.77M, a 9.19% decline from fiscal 2022.
- AGIOS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $49.30M, a 7.87% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $15.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $31.48M 10-Q · filed 2026-07-30 | $45.61M derived: sum of 3 quarters · filed 2026-07-30 | $57.98M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $15.54M 10-Q · filed 2026-04-29 | $29.66M derived: sum of 2 quarters · filed 2026-04-29 | $42.04M derived: sum of 3 quarters · filed 2026-04-29 | $56.73M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $14.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $26.50M derived: sum of 2 quarters · filed 2026-02-12 | $41.19M derived: sum of 3 quarters · filed 2026-07-30 | $52.55M 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | $12.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $27.07M derived: sum of 2 quarters · filed 2026-07-30 | $38.43M 10-Q · filed 2025-10-30 | $49.33M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $14.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $26.05M 10-Q · filed 2026-07-30 | $36.95M derived: sum of 3 quarters · filed 2026-07-30 | $48.10M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $11.36M 10-Q · filed 2026-04-29 | $22.26M derived: sum of 2 quarters · filed 2026-04-29 | $33.41M derived: sum of 3 quarters · filed 2026-04-29 | $44.97M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $10.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $22.05M derived: sum of 2 quarters · filed 2026-02-12 | $33.61M derived: sum of 3 quarters · filed 2026-02-12 | $42.85M 10-K · filed 2026-02-12 | ||||
| 2024-09-30 | $11.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $22.71M derived: sum of 2 quarters · filed 2025-10-30 | $31.94M 10-Q · filed 2025-10-30 | $45.76M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | $11.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $20.80M 10-Q · filed 2025-07-31 | $34.61M derived: sum of 3 quarters · filed 2026-02-12 | $43.69M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-03-31 | $9.23M 10-Q · filed 2025-05-01 | $23.05M derived: sum of 2 quarters · filed 2026-02-12 | $32.12M derived: sum of 3 quarters · filed 2026-02-12 | $43.86M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2023-12-31 | $13.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $22.89M derived: sum of 2 quarters · filed 2026-02-12 | $34.63M derived: sum of 3 quarters · filed 2026-02-12 | $44.77M 10-K · filed 2026-02-12 | ||||
| 2023-09-30 | $9.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $20.81M derived: sum of 2 quarters · filed 2024-10-31 | $30.95M 10-Q · filed 2024-10-31 | $42.42M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $11.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $21.88M 10-Q · filed 2024-08-01 | $33.34M derived: sum of 3 quarters · filed 2025-02-13 | $44.50M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $10.14M 10-Q · filed 2024-05-02 | $21.60M derived: sum of 2 quarters · filed 2025-02-13 | $32.76M derived: sum of 3 quarters · filed 2025-02-13 | $43.92M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $11.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $22.62M derived: sum of 2 quarters · filed 2025-02-13 | $33.79M derived: sum of 3 quarters · filed 2025-02-13 | $49.30M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $11.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $22.32M derived: sum of 2 quarters · filed 2023-11-02 | $37.83M 10-Q · filed 2023-11-02 | $49.45M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $11.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $26.68M 10-Q · filed 2023-08-03 | $38.30M derived: sum of 3 quarters · filed 2024-02-15 | $50.44M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | $15.51M 10-Q · filed 2023-05-04 | $27.13M derived: sum of 2 quarters · filed 2024-02-15 | $39.28M derived: sum of 3 quarters · filed 2024-02-15 | $54.16M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $11.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $23.77M derived: sum of 2 quarters · filed 2024-02-15 | $38.65M derived: sum of 3 quarters · filed 2024-02-15 | $53.51M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $12.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $27.03M derived: sum of 2 quarters · filed 2022-11-03 | $41.89M 10-Q · filed 2022-11-03 | $55.23M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $14.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $29.74M 10-Q · filed 2022-08-04 | $43.08M derived: sum of 3 quarters · filed 2023-02-23 | $58.06M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $14.85M 10-Q · filed 2022-05-05 | $28.20M derived: sum of 2 quarters · filed 2023-02-23 | $43.17M derived: sum of 3 quarters · filed 2023-02-23 | $60.79M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $13.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $28.32M derived: sum of 2 quarters · filed 2023-02-23 | $45.93M derived: sum of 3 quarters · filed 2023-02-23 | $61.60M 10-K · filed 2023-02-23 | $75.12M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $14.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $32.59M derived: sum of 2 quarters · filed 2021-11-03 | $48.26M 10-Q · filed 2021-11-03 | $58.53M 10-Q · filed 2020-11-05 | $51.07M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | $17.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $33.28M 10-Q · filed 2021-07-29 | $40.12M 10-Q · filed 2020-07-30 | $36.09M derived: sum of 3 quarters · filed 2022-02-24 | $54.68M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | $15.67M 10-Q · filed 2021-04-29 | $19.69M 10-Q · filed 2020-04-30 | $18.48M derived: sum of 2 quarters · filed 2022-02-24 | $37.06M derived: sum of 3 quarters · filed 2022-02-24 | $55.61M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $21.39M derived: sum of 2 quarters · filed 2022-02-24 | $39.94M derived: sum of 3 quarters · filed 2022-02-24 | $58.05M 10-K · filed 2022-02-24 | $72.37M 10-K · filed 2020-02-19 | |||
| 2019-09-30 | $18.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $37.13M derived: sum of 2 quarters · filed 2020-11-05 | $55.24M 10-Q · filed 2020-11-05 | $73.43M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $18.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $36.66M 10-Q · filed 2020-07-30 | $54.84M derived: sum of 3 quarters · filed 2021-02-25 | $79.03M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $18.11M 10-Q · filed 2020-04-30 | $36.30M derived: sum of 2 quarters · filed 2021-02-25 | $60.49M derived: sum of 3 quarters · filed 2021-02-25 | $76.94M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $18.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $42.38M derived: sum of 2 quarters · filed 2021-02-25 | $58.84M derived: sum of 3 quarters · filed 2021-02-25 | $73.36M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $24.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $40.65M derived: sum of 2 quarters · filed 2019-10-31 | $55.17M 10-Q · filed 2019-10-31 | $67.85M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $16.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $30.98M 10-Q · filed 2019-08-01 | $43.66M derived: sum of 3 quarters · filed 2020-02-19 | $55.87M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $14.52M 10-Q · filed 2019-05-02 | $27.20M derived: sum of 2 quarters · filed 2020-02-19 | $39.41M derived: sum of 3 quarters · filed 2020-02-19 | $51.60M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $12.68M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $24.89M derived: sum of 2 quarters · filed 2020-02-19 | $37.08M derived: sum of 3 quarters · filed 2020-02-19 | $47.81M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $12.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $24.39M derived: sum of 2 quarters · filed 2018-11-01 | $35.13M 10-Q · filed 2018-11-01 | $44.97M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-06-30 | $12.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $22.92M 10-Q · filed 2018-08-02 | $32.76M derived: sum of 3 quarters · filed 2019-02-14 | $44.90M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-03-31 | $10.73M 10-Q · filed 2018-05-04 | $20.57M derived: sum of 2 quarters · filed 2019-02-14 | $32.72M derived: sum of 3 quarters · filed 2019-02-14 | $43.71M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2016-12-31 | $9.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $21.98M derived: sum of 2 quarters · filed 2019-02-14 | $32.98M derived: sum of 3 quarters · filed 2019-02-14 | $42.09M 10-K · filed 2019-02-14 | ||||
| 2016-09-30 | $12.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $23.14M derived: sum of 2 quarters · filed 2017-11-01 | $32.25M 10-Q · filed 2017-11-01 | $41.60M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-06-30 | $11.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $20.10M 10-Q · filed 2017-08-08 | $29.46M derived: sum of 3 quarters · filed 2018-02-14 | $38.83M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-03-31 | $9.11M 10-Q · filed 2017-05-04 | $18.46M derived: sum of 2 quarters · filed 2018-02-14 | $27.83M derived: sum of 3 quarters · filed 2018-02-14 | $36.01M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2015-12-31 | $9.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $18.73M derived: sum of 2 quarters · filed 2018-02-14 | $26.90M derived: sum of 3 quarters · filed 2018-02-14 | $31.96M 10-K · filed 2018-02-14 | ||||
| 2015-09-30 | $9.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $17.55M derived: sum of 2 quarters · filed 2016-11-03 | $22.61M 10-Q · filed 2016-11-03 | $27.34M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | $8.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $13.24M 10-Q · filed 2016-08-08 | $17.96M derived: sum of 3 quarters · filed 2017-02-16 | $20.86M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | $5.06M 10-Q · filed 2016-05-09 | $9.79M derived: sum of 2 quarters · filed 2017-02-16 | $12.68M derived: sum of 3 quarters · filed 2017-02-16 | $15.06M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2014-12-31 | $4.73M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $7.62M derived: sum of 2 quarters · filed 2017-02-16 | $10.00M derived: sum of 3 quarters · filed 2017-02-16 | $11.51M 10-K · filed 2017-02-16 | ||||
| 2014-09-30 | $2.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $5.27M derived: sum of 2 quarters · filed 2015-11-06 | $6.78M 10-Q · filed 2015-11-06 | $7.94M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $3.89M 10-Q · filed 2015-08-07 | $5.05M derived: sum of 3 quarters · filed 2016-02-26 | $6.16M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $1.50M 10-Q · filed 2015-05-11 | $2.67M derived: sum of 2 quarters · filed 2016-02-26 | $3.78M derived: sum of 3 quarters · filed 2016-02-26 | $4.11M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $2.28M derived: sum of 2 quarters · filed 2016-02-26 | $2.61M derived: sum of 3 quarters · filed 2016-02-26 | $3.03M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $1.44M derived: sum of 2 quarters · filed 2014-11-07 | $1.86M 10-Q · filed 2014-11-07 | $2.25M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $329.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $753.00K 10-Q · filed 2014-08-07 | $1.14M derived: sum of 3 quarters · filed 2015-02-24 | $1.31M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $424.00K 10-Q · filed 2014-05-09 | $807.00K derived: sum of 2 quarters · filed 2015-02-24 | $977.00K derived: sum of 3 quarters · filed 2015-02-24 | |||||
| 2012-12-31 | $383.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $553.00K derived: sum of 2 quarters · filed 2015-02-24 | $742.00K 10-K · filed 2015-02-24 | |||||
| 2012-09-30 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $359.00K 10-Q · filed 2013-11-07 | ||||||
| 2012-06-30 | $189.00K 10-Q · filed 2013-09-05 | |||||||
| 2011-12-31 | $371.00K 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |